Long
Cancer Treatment - Ready to Spike
It looks like this stock is ready to spike.
On 6/10/2020, NK said its NK cells appear to be resistant even to acute hypoxia and are capable of maintaining tumor killing activity in conditions comparable with a suppressive tumor microenvironment.
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
On 6/10/2020, NK said its NK cells appear to be resistant even to acute hypoxia and are capable of maintaining tumor killing activity in conditions comparable with a suppressive tumor microenvironment.
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.